Two Directors at ConocoPhillips sold/bought 3,163 shares at between 0.000USD and 95.870USD. The significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Global Partners LP ("Global") and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 17 December 2024 in which we reassessed the appropriateness of the ratings in...
A director at Culp Inc bought 5,000 shares at 5.550USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies • PRT2527 demonstrated activity across a range of relapsed/refractory lymphoid malignancies, including patients who received prior CAR-T therapy • Prelude plans to seek a partner for future development of PRT2527 in hematologic malignancies WILMINGTON, Del., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a cl...
Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch Strong Eversense® 365 early launch indicators illustrated by largest number of new patient shipments and largest number of prescribing providers in any month under Ascensia partnership GERMANTOWN, Md., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today provided commercial updates related to the Eversense® 365 launch. ...
Bring Home 2025’s Cottage Chic Trend With The Tile Shop’s Newest Collaboration With Laura Ashley The Laura Ashley tile collection is available exclusively at The Tile Shop’s 142 U.S. showrooms and tileshop.com MINNEAPOLIS, Dec. 06, 2024 (GLOBE NEWSWIRE) -- As 2024 comes to a close, new reports from Zillow1 and Houzz2 indicate that Cottage Chic style will be a dominant design trend of 2025. But homeowners don’t need to wait until 2025 to get in on the trend, because The Tile Shop is ready to help you embrace Cottage Chic design right now with and , the newest tiles in its exclusive col...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.